BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30063259)

  • 1. Treatment Barriers in Portopulmonary Hypertension.
    AbuHalimeh B; Krowka MJ; Tonelli AR
    Hepatology; 2019 Jan; 69(1):431-443. PubMed ID: 30063259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new in the treatment of portopulmonary hypertension?
    DuBrock HM; Channick RN; Krowka MJ
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    DuBrock HM
    Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management approaches to portopulmonary hypertension.
    Savale L; O'Callaghan DS; Magnier R; Le Pavec J; Hervé P; Jaïs X; Seferian A; Humbert M; Simonneau G; Sitbon O
    Int J Clin Pract Suppl; 2011 Jan; (169):11-8. PubMed ID: 21176011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portopulmonary hypertension.
    Al-Naamani N; Roberts KE
    Clin Chest Med; 2013 Dec; 34(4):719-37. PubMed ID: 24267301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension.
    Lv Y; Han G; Fan D
    Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
    Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
    Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The portopulmonary hypertension: an overview from diagnosis to treatment].
    Salzano A; Sirico D; Golia L; Faga V; Flora M; Bossone E; Cittadini A
    Monaldi Arch Chest Dis; 2013 Jun; 80(2):66-8. PubMed ID: 24494409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative anesthetic management of the liver transplant recipient with portopulmonary hypertension.
    Kandil S
    Curr Opin Organ Transplant; 2019 Apr; 24(2):121-130. PubMed ID: 30762664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
    Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
    BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
    Awdish RL; Cajigas HR
    Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
    Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
    J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in portopulmonary hypertension: a 20-year experience.
    Aggarwal M; Li M; Bhardwaj A; Wallace WD; Wang X; Carey WD; Dweik RA; Heresi GA; Tonelli AR
    Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):449-456. PubMed ID: 34907982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
    Kähler CM; Graziadei I; Vogelsinger H; Desole S; Cima K; Vogel W
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):248-52. PubMed ID: 21451953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
    Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Struggling Between Liver Transplantation and Portopulmonary Hypertension.
    Jose A; Jones CR; Elwing JM
    Heart Fail Clin; 2023 Jan; 19(1):55-65. PubMed ID: 36435573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portopulmonary hypertension.
    Krowka MJ
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, Treatment, and Management of Orthotopic Liver Transplant Candidates With Portopulmonary Hypertension.
    Koulava A; Sannani A; Levine A; Gupta CA; Khanal S; Frishman W; Bodin R; Wolf DC; Aronow WS; Lanier GM
    Cardiol Rev; 2018; 26(4):169-176. PubMed ID: 29608499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of portopulmonary hypertension.
    Medarov BI; Chopra A; Judson MA
    Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.